Back
Kellanova Vs. Akero Therapeutics Industry Stock Comparison
Sell
50
K
Kellanova
Last Price:
60.49
Seasonality Move:
3.96%
Sell
40
AKRO
Akero Therapeutics
Last Price:
19.64
Seasonality Move:
6.97%
Sell
50
Kellanova (K)
is a Sell
Is Kellanova a Buy, Sell or Hold?
- The current Kellanova [K] share price is $60.51. The Score for K is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
- K is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
40
Akero Therapeutics (AKRO)
is a Sell
Is Akero Therapeutics a Buy, Sell or Hold?
- The current Akero Therapeutics [AKRO] share price is $19.66. The Score for AKRO is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
- AKRO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
K Stock Price Chart
AKRO Stock Price Chart
What is Akero Therapeutics's stock price today?
-
The Akero Therapeutics share price today is $19.66
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and AKRO is experiencing selling pressure, which indicates risk of future bearish movement.
K Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.92 | Buy |
| Relative Strength Index (14 RSI): | 64.92 | Buy |
| Chaikin Money Flow: | 869847 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (56.09 - 58.81) | Buy |
| Bollinger Bands (100): | (53.99 - 57.19) | Buy |
AKRO Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.19 | Sell |
| Relative Strength Index (14 RSI): | 35.02 | Sell |
| Chaikin Money Flow: | -513518 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (19.95 - 22.91) | Sell |
| Bollinger Bands (100): | (20.21 - 26.05) | Sell |
K Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 58.72 | Buy |
| 20-day SMA: | 57.5 | Buy |
| 50-day SMA: | 56.21 | Buy |
| 200-day SMA: | 56.34 | Buy |
| 8-day EMA: | 58.9 | Buy |
| 20-day EMA: | 57.86 | Buy |
| 50-day EMA: | 56.69 | Buy |
| 200-day EMA: | 57.52 | Buy |
AKRO Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 19.73 | Sell |
| 20-day SMA: | 20.95 | Sell |
| 50-day SMA: | 24.31 | Sell |
| 200-day SMA: | 28.19 | Sell |
| 8-day EMA: | 19.96 | Sell |
| 20-day EMA: | 20.99 | Sell |
| 50-day EMA: | 22.48 | Sell |
| 200-day EMA: | 27.07 | Sell |
Kellanova Earnings Growth & K Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.06 per share, an increase next quarter of $0.11 per share, a decrease this year of $0.52 per share, and an increase next year of $0.22 per share.
Akero Therapeutics Earnings Growth & AKRO Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.32 per share, a decrease next quarter of $0.19 per share, a decrease this year of $1.01 per share, and a decrease next year of $0.65 per share.
Kellanova Technical Analysis
| Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | May 3 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 22 | 23 | 24 | 25 | 26 | 29 | 30 | 01 | 02 | 03 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Akero Therapeutics Technical Analysis
| Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | May 3 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 22 | 23 | 24 | 25 | 26 | 29 | 30 | 01 | 02 | 03 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||